Antiretroviral raltegravir, a selective human immunodeficiency virus type 1 integrase inhibitor, shows anti-Alzheimer’s potential against amyloid-beta1–42-induced neurodegeneration

Mechanisms of Ageing and Development 2026

View at publisher
Authors: Mehdi Alami, Hicham Berrougui, Kaoutar Boumezough, Ikram Salih, Khalid Sadki, Benoît Laurent, Olaf van Tellingen, Ton Bunt, Abdelouahed Khalil, Tamàs Fülöp
DOI: 10.1016/j.mad.2026.112161
Cited by: 0
References: 47

Fields of Study & Subjects

Alzheimer's disease research and treatments Neuroinflammation and Neurodegeneration Mechanisms Dementia and Cognitive Impairment Research

Publication details

Journal / source
Mechanisms of Ageing and Development
Volume
231
Pages
112161–112161
Publication date
16 February 2026
Language
EN